Autosomal recessive osteopetrosis: mechanisms and treatments.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 05 2021
Historique:
entrez: 10 5 2021
pubmed: 11 5 2021
medline: 26 2 2022
Statut: ppublish

Résumé

Autosomal recessive osteopetrosis (ARO) is a severe inherited bone disease characterized by defective osteoclast resorption or differentiation. Clinical manifestations include dense and brittle bones, anemia and progressive nerve compression, which hamper the quality of patients' lives and cause death in the first 10 years of age. This Review describes the pathogenesis of ARO and highlights the strengths and weaknesses of the current standard of care, namely hematopoietic stem cell transplantation (HSCT). Despite an improvement in the overall survival and outcomes of HSCT, transplant-related morbidity and the pre-existence of neurological symptoms significantly limit the success of HSCT, while the availability of human leukocyte antigen (HLA)-matched donors still remains an open issue. Novel therapeutic approaches are needed for ARO patients, especially for those that cannot benefit from HSCT. Here, we review preclinical and proof-of-concept studies, such as gene therapy, systematic administration of deficient protein, in utero HSCT and gene editing.

Identifiants

pubmed: 33970241
pii: 261835
doi: 10.1242/dmm.048940
pmc: PMC8188884
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Mol Ther. 2017 May 3;25(5):1132-1141
pubmed: 28366768
Hum Mutat. 2010 Jan;31(1):E1071-80
pubmed: 19953639
Pediatr Blood Cancer. 2016 Mar;63(3):535-40
pubmed: 26485304
Cell. 2001 Jan 26;104(2):205-15
pubmed: 11207362
Nat Biotechnol. 2016 Jul;34(7):738-45
pubmed: 27272386
Bone Marrow Transplant. 2015 Dec;50(12):1583-5
pubmed: 26367231
J Pediatr. 1994 Dec;125(6 Pt 1):896-902
pubmed: 7996361
Blood. 2002 May 1;99(9):3458-60
pubmed: 11964318
Biol Blood Marrow Transplant. 2015 Mar;21(3):473-82
pubmed: 25485863
Sci Rep. 2018 Apr 30;8(1):6701
pubmed: 29712939
J Ayub Med Coll Abbottabad. 2017 Apr-Jun;29(2):350-352
pubmed: 28718264
Mol Med Rep. 2019 Jun;19(6):5030-5038
pubmed: 30942407
Biochem Biophys Res Commun. 1998 Dec 18;253(2):395-400
pubmed: 9878548
Stem Cell Res. 2019 Mar;35:101367
pubmed: 30763735
Lancet Haematol. 2020 Feb;7(2):e134-e145
pubmed: 31704264
J Med Genet. 2012 Apr;49(4):221-6
pubmed: 22499339
J Clin Invest. 2007 Apr;117(4):919-30
pubmed: 17404618
Am J Pathol. 2009 Mar;174(3):727-35
pubmed: 19218349
Bone Marrow Transplant. 2006 Oct;38(8):547-53
pubmed: 16953210
Nat Commun. 2019 Feb 6;10(1):616
pubmed: 30728353
Bone Marrow Transplant. 2021 Feb;56(2):434-441
pubmed: 32855443
Pediatr Blood Cancer. 2018 Jun;65(6):e27010
pubmed: 29469225
Haematologica. 2020 Jan 16;106(1):74-86
pubmed: 31949009
J Bone Miner Res. 2017 Jan;32(1):82-85
pubmed: 27447118
Curr Opin Hematol. 2012 Nov;19(6):440-7
pubmed: 22954723
J Bone Miner Res. 2012 Dec;27(12):2501-10
pubmed: 22836362
Biol Blood Marrow Transplant. 2005 Feb;11(2):115-21
pubmed: 15682072
Nature. 2019 Apr;568(7753):541-545
pubmed: 30971820
Clin Dev Immunol. 2013;2013:412768
pubmed: 23762088
Nat Genet. 2000 Jul;25(3):343-6
pubmed: 10888887
Bone Marrow Transplant. 2003 Oct;32(7):657-63
pubmed: 13130312
Genet Med. 2017 Oct;19(10):1144-1150
pubmed: 28383543
Science. 2010 Jun 11;328(5984):1398-401
pubmed: 20430975
J Bone Miner Res. 2013 May;28(5):1041-9
pubmed: 23280965
Bone. 2013 Nov;57(1):1-9
pubmed: 23907031
Blood. 2007 Jun 15;109(12):5178-85
pubmed: 17332244
Pediatr Blood Cancer. 2021 Mar;68(3):e28841
pubmed: 33314591
Cell. 1998 Apr 17;93(2):165-76
pubmed: 9568710
Bone Rep. 2020 Jan 07;12:100242
pubmed: 31938717
Biol Blood Marrow Transplant. 2016 Nov;22(11):1997-2002
pubmed: 27470286
J Bone Miner Res. 2020 Jul;35(7):1322-1332
pubmed: 32119750
J Bone Miner Res. 2015 Oct;30(10):1814-21
pubmed: 25829125
Exp Hematol. 2006 Feb;34(2):242-9
pubmed: 16459192
Nat Med. 2009 Jun;15(6):674-81
pubmed: 19448635
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3111-3123
pubmed: 28655174
Orphanet J Rare Dis. 2009 Feb 20;4:5
pubmed: 19232111
Stem Cell Res Ther. 2020 May 15;11(1):179
pubmed: 32414402
Nat Med. 2009 Mar;15(3):313-8
pubmed: 19234460
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14629-34
pubmed: 16195375
J Bone Miner Res. 2021 Mar;36(3):531-545
pubmed: 33125761
J Cell Biochem. 2019 Oct;120(10):17180-17193
pubmed: 31111556
Exp Cell Res. 2014 Oct 15;328(1):32-43
pubmed: 25152440
Hum Mol Genet. 2012 Nov 15;21(22):4904-9
pubmed: 22875837
Stem Cells Transl Med. 2019 Jan;8(1):22-34
pubmed: 30184340
Bone Marrow Transplant. 2019 Jul;54(7):961-968
pubmed: 30664721
J Bone Miner Res. 2012 Feb;27(2):342-51
pubmed: 22271396
J Cell Biol. 2011 Mar 7;192(5):883-97
pubmed: 21357746
Bone. 2000 Mar;26(3):207-13
pubmed: 10709991
Front Endocrinol (Lausanne). 2019 Feb 19;10:85
pubmed: 30837952
Nat Commun. 2019 Feb 6;10(1):617
pubmed: 30728354
Nat Rev Endocrinol. 2013 Sep;9(9):522-36
pubmed: 23877423
Nat Med. 2003 Apr;9(4):399-406
pubmed: 12627228
J Oral Maxillofac Surg. 2016 Aug;74(8):1584-95
pubmed: 27000409
Blood Adv. 2019 Feb 12;3(3):237-241
pubmed: 30683657
Bone. 2019 Mar;120:495-503
pubmed: 30537558
Blood. 2011 Apr 21;117(16):4367-75
pubmed: 21325599
Stem Cell Reports. 2015 Oct 13;5(4):558-68
pubmed: 26344905
Hum Gene Ther. 2019 Nov;30(11):1395-1404
pubmed: 31179768
J Med Genet. 2016 Aug;53(8):568-74
pubmed: 27055475
Clin Genet. 2017 Jun;91(6):902-907
pubmed: 27808398
Blood. 2015 Jul 9;126(2):270-6
pubmed: 26012570
Lancet. 2009 Sep 12;374(9693):912-20
pubmed: 19729196
J Bone Joint Surg Am. 2019 Nov 6;101(21):1939-1947
pubmed: 31567691
EMBO J. 2011 Jun 1;30(11):2140-52
pubmed: 21527911
Curr Hematol Malig Rep. 2017 Feb;12(1):68-78
pubmed: 28116633
Blood Adv. 2019 Mar 26;3(6):862-868
pubmed: 30885997
Biomaterials. 2015 Apr;46:58-69
pubmed: 25678116
Curr Osteoporos Rep. 2018 Feb;16(1):13-25
pubmed: 29335834
J Allergy Clin Immunol. 2021 Jan;147(1):309-320.e6
pubmed: 32387109
Hum Gene Ther. 2018 Aug;29(8):938-949
pubmed: 28726516
Nat Rev Genet. 2021 Apr;22(4):216-234
pubmed: 33303992
Biol Blood Marrow Transplant. 2019 Jul;25(7):1363-1373
pubmed: 30876929
Science. 1996 Aug 30;273(5279):1236-8
pubmed: 8703060
Proc Natl Acad Sci U S A. 1983 May;80(9):2752-6
pubmed: 6405388
Blood Adv. 2019 Sep 24;3(18):2700-2711
pubmed: 31515232
Calcif Tissue Int. 2016 Dec;99(6):638-648
pubmed: 27541021

Auteurs

Sara Penna (S)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
Translational and Molecular Medicine (DIMET), University of Milano-Bicocca, Monza 20900, Italy.

Anna Villa (A)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
Institute of Genetic and Biomedical Research, Milan Unit, National Research Council, Milan 20090, Italy.

Valentina Capo (V)

San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.
Institute of Genetic and Biomedical Research, Milan Unit, National Research Council, Milan 20090, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH